Clinical Trial: Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07466420) titled 'Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.' on Feb. 02.

Brief Summary: Fibrotic interstitial lung diseases (F-ILDs), including both idiopathic pulmonary fibrosis (IPF) and non-IPF, are chronic and progressive lung diseases characterized by excessive scarring of lung tissue, leading to declining lung function, respiratory failure, and high mortality, despite the currently approved antifibrotic treatment. While its exact cause remains unknown, pulmonary fibrosis is strongly linked to aging, genetic predisposition, environmental factors, and cellular senescence. Ongoing research aim...